An Unprecedented Investment Opportunity

Recs

7

Here's reality: Hundreds of hotshot money managers and analysts convened at the Marriott Marquis in New York last fall to attend J.P. Morgan's annual Asia Pacific and Emerging Markets Equity Conference. My guarantee to you is that they weren't there because they're scared of investing in emerging-markets stocks.

But you very well might be ... and I can't necessarily blame you.

Some very scary numbers
China, India, Indonesia, Brazil ... what do these emerging markets have in common? They were all absolutely crushed last year. China was underwater to the tune of 60%, Indonesia and India 50%, and Brazil 40%.

It's been a tough and volatile year for emerging-markets investors, and those who naively came to believe (thanks to the 2003 to 2007 period) that emerging-markets investing was all about outsized gains are scurrying away with their tails between their legs.

This, however, is precisely the wrong time for that kind of reaction.

Take China, for example
The first session at the closed-door conference came courtesy of famed author, investor, and Princeton economist Burton Malkiel. His presentation, titled "Investment Strategies for the China Century," can be summarized as follows:

  1. Though China's GDP growth is slowing, it will remain the fastest in the world (a fact verified today by the World Bank).
  2. If you're an American investor, you're lucky to have even 2% exposure to China -- and that makes you dangerously underexposed.
  3. The recent decline in China stock valuations, together with the magnitude and duration of China's potential growth, makes today an "unprecedented investment opportunity."

Those are his words, not mine, though I do agree. The question, of course, is how does the individual American investor take advantage of this unprecedented opportunity?

Your four options
If you're an American investor looking for maximum returns and minimum hassle, then you have four ways to buy China:

  1. Buy a Chinese index fund, such as the iShares FTSE/Xinhua China 25 (NYSE: FXI).
  2. Buy an actively managed mutual fund -- such as Matthews China -- that is concentrated in China.
  3. Buy multinational corporations such as Wal-Mart (NYSE: WMT), Toyota (NYSE: TM), and even Joy Global (Nasdaq: JOYG) that are expanding in China and that have made doing business in China a significant part of their growth strategy.
  4. Buy individual Chinese stocks such as Zhongpin (Nasdaq: HOGS) and China Sky One Medical (Nasdaq: CSKI) that trade on U.S. exchanges.

Each one of these approaches comes with its own set of pluses and minuses. Though the index fund is low-cost, for example, it will condemn your portfolio to holding nothing but enormous, bureaucratic, state-owned enterprises such as China Telecom. The actively managed fund might make more discerning stock picks, but it's also expensive -- and Malkiel's research showed that most actively managed China funds substantially underperform the index.

Can you pick your own stocks?
That leaves two options: Picking your own multinationals or picking your own Chinese stocks. In fact, Malkiel recommends you do both.

Of course, you'll probably feel more comfortable researching U.S. stocks that have a CEO who speaks your language (literally), that sell products familiar to you, and that release financials you're more likely to trust.

That's particularly so since Malkiel recommends that when you're picking Chinese stocks, you avoid the big state-owned enterprises and instead focus on small caps that are run by passionate entrepreneurs, rather than the cautious (and Communist) Chinese government. These stocks have more potential and more upside, and they're more likely to have been heretofore overlooked by institutional money -- so you might get a screaming bargain.

To do so, however, you need to know a thing or two about China. And at Motley Fool Global Gains, we'd like to help you with that.

Here's why
We've traveled to China twice over the past year, established a network of contacts, and specialize in finding and vetting promising Chinese small caps that we believe have the potential to be multibaggers many times over for many years. And we're hitting the road for India at the end of the month and plan to compare that country's top stocks with what we've found in China.

If you'd like to get the results of those comparisons, sign up to receive all of our insights from the field. They're free and all you have to do is tell us where to send them. Click here to do just that.

This article was first published Sept. 12, 2008. It has been updated.

Tim Hanson does not own shares of any company mentioned. Wal-Mart is a Motley Fool Inside Value recommendation. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 21, 2009, at 9:13 AM, jonboy13 wrote:

    I've been a real 'Fool' for some time and I feel this is the most important article I've seen here.

  • Report this Comment On November 21, 2009, at 9:54 PM, tkell31 wrote:

    Got into CGA and PWRD about six months ago based on an article here, and just recently took positions in APWR and CMFO. I mildly worry about nationalization possibilities or the chance that the books aren't accurate, but so much upside I figure it is worth the risk.

  • Report this Comment On November 21, 2009, at 10:14 PM, topsecret09 wrote:

    On August 26th, China Sky One Medical, Inc. (NASDAQ: CSKI) issued a press release addressing discrepancies between financial statements filed with the China State Administration of Industry and Commerce (“SAIC”) and statements filed with the U.S. Securities and Exchange Commission (“SEC”). asensio.com first reported on the discrepancies in a report issued on August 6th.

    CSKI’s press release admits that its SAIC filings are not consistent with its SEC filings. The release states, “The Company [CSKI] has determined these financial reports are materially different from the financial reports filed with the SEC.” The statement that the “Company has determined” is especially odd, given that the discrepancy was revealed by an outside party, and that CSKI management, based in China, should have been aware of the discrepancy prior to an outside party reporting it.

    A major issue from the asensio.com report left unaddressed by CSKI is the small amount of revenue reported by CSKI’s suppliers and customers, which CSKI has disclosed. These other companies’ SAIC-filed financial statements are also much lower than the level of revenues reported in CSKI’s SEC filings.

    The previous asensio.com report mentioned that CSKI’s main operating subsidiary, Harbin Tian Di Ren Medical Science and Technology Co. (“TDR”) showed revenue of only about $1.3 million and net income of only $1,000 in its SAIC-filed income statement for 2007, compared to the $49 million in revenue and $15 million in net income reported in CSKI’s SEC-filed Form 10-K for 2007. Credit reports show TDR's 2008 figures to be equally inconsistent. Is this company a fraud ? Lets See ....... TS

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 1049414, ~/Articles/ArticleHandler.aspx, 2/9/2010 10:36:25 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Is This Bull Over?

By The Motley Fool

Is This Bull Over?

Related Tickers

2/9/2010 4:00 PM
HOGS $11.90 Up +0.12 +1.02%
ZHONGPIN INC. CAPS Rating: *****
FXI $38.46 Up +1.29 +3.47%
iShares FTSE/Xinhu… CAPS Rating: ***
JOYG $45.73 Up +1.22 +2.74%
Joy Global, Inc. CAPS Rating: ****
TM $74.60 Up +1.75 +2.40%
Toyota Motor Corp… CAPS Rating: **
CSKI $17.44 Up +0.29 +1.69%
China Sky One Medi… CAPS Rating: ****
WMT $53.25 Up +0.32 +0.60%
Wal-Mart Stores, I… CAPS Rating: ***

Community: Investing Wiki

Term Of The Hour

Operating margin: Operating margin is defined as Operating Profit divided by Revenue (or Sales).

Want to learn more or edit this definition?
Click here to read more!